An EEG Study on the Rhythmic Nature of Perception and Attention

April 8, 2024 updated by: Luca Ronconi, Università Vita-Salute San Raffaele

EEG Study of the Rhythmic Nature of Human Visual Perception and Attention

The study involved healthy volunteers (n= 200), in a single center, low-risk intervention protocol of a non-profit nature. The objective of the study is to investigate the neural mechanisms of visual perception and attention, with particular reference to neural oscillations, in the general population through electroencephalogram (EEG) recording and the administration of simple visual tasks on a PC. The study presented is not associated with risks, as EEG is a non-invasive technique for which there are no known contraindications or adverse reactions.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Italy
      • Milan, Italy, 20132
        • Recruiting
        • IRCCS Ospedale San Raffaele
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy human volunteers

Description

Inclusion Criteria:

  • age between 18 and 35 years
  • able/willing to sign the informed consent
  • normal or corrected-to-normal vision and hearing

Exclusion Criteria:

- history of severe/major neurological or psychiatric conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electroencephalographic (EEG) oscillatory amplitude
Time Frame: during the intervention
Amplitude of EEG oscillations in theta, alpha and beta frequency bands
during the intervention
Electroencephalographic (EEG) oscillatory frequency
Time Frame: during the intervention
Frequency of EEG oscillations in theta, alpha and beta frequency bands
during the intervention
Electroencephalographic (EEG) oscillatory phase coherence
Time Frame: during the intervention
Phase coherence of EEG oscillations in theta, alpha and beta frequency bands
during the intervention
Autism Quotient (AQ)
Time Frame: during the intervention
Personality questionnaire measuring subclinical autistic traits. Higher score mean worse outcome. Score range: min.= 0, max.= 50.
during the intervention
Schizotypal Personality Questionnaire (SPQ)
Time Frame: during the intervention
Personality questionnaire measuring subclinical schizotypal traits. Higher score mean worse outcome. Score range: min.= 0, max.= 74.
during the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Università Vita-Salute San Raffaele

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

January 8, 2024

First Submitted That Met QC Criteria

January 23, 2024

First Posted (Actual)

February 1, 2024

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 8, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EEGVISION-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Human Brain and Cognition

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe